PSS20 COST-EFFECTIVENESS OF TOBRADEX VERSUS ZYLET FOR THE TREATMENT OF BLEPHAROKERATOCONJUNCTIVITIS
Abstract
Authors
A Rahman C Waycaster D Smith
A Rahman C Waycaster D Smith
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now